-
INTENSIFYING DRUG CRUNCH
-
Acknowledgements
-
Targeting Optimal DRUG DELIVERY
-
Japan approves digital therapeutic CureApp for hypertension
-
China, Brazil join hands to boost health cooperation
-
UKHSA inks agreement with KDCA for disease control and prevention
-
Singapore announces new collaborative project for cardiovascular disease research
-
Korea, Bangladesh join forces to boost AMR response in South Asia
-
NZ announces $40.7M funding for mRNA vaccines development
-
Varian partners with Icon Group to advance patient-centric solutions
-
Fujifilm Irvine Scientific completes construction of bioprocessing centre in China
-
Dr. Reddy’s signs multicountry deal with HK inno.N for Tegoprazan
-
WuXi, A*STAR make advancements with cell and gene therapy in APAC
-
Novo Holdings, Shionogi offer treatment for invasive fungal infections in Asia
-
Hyundai Bioscience opens new chapter in world’s antiviral drug history
-
India-Australia’s COVID-19 vaccine project gets $19.3M funding
-
Fosun Pharma inks $125M deal for novel immunotherapies in China
-
Hanmi FC to invest 10 billion KRW for building facilities for ‘high-tech CDMOs’
-
India unveils angel investor network for biotech startups
-
Ankere Therapeutics launches with A$10M seed investment in Australia
-
InxMed raises $15M to advance therapies for drugresistant cancers
-
Biopharma Helico gets seed funding for producing edible medicines
-
SwipeRx secures $27M to accelerate growth across SEA
-
DoctorOnCall bridges gap between HCPs and patients
-
US to set up 9 AViDD Centres for Pathogens of Pandemic Concern
-
DFC financing up to $1B for Gavi COVID-19 vaccine supply
-
EffRx, Medis, Orpharm, OrphanDC, Vector Pharma form WODA
-
Ethiopia establishes collaborating centre with Korea for joint vaccine research
-
Kenya to assess mix-and-match COVID-19 vaccine boosters in people living with HIV
-
Benin, Uganda, Rwanda eliminate human African trypanosomiasis
-
WHO compiles innovative concepts to communicate science
-
WHO launches new guide on integrating eye care in health systems
-
WHO validates China’s Convidecia as 11th vaccine for COVID-19
-
GLOBAL DDD MARKET
-
5 TYPES OF DDD COMPANIES
-
OTHER FLAGSHIP INTERVENTIONS OF AIM THAT HAVE ALREADY MADE A HUGE IMPACT
-
Johns Hopkins Bloomberg School of Public Health honours Dr Cyrus Poonawalla
-
Genexine appoints Neil Warma as CEO
-
CANbridge Pharma names Dr Pauline Li as SVP of Clinical Development
-
Dr Shreeram Aradhye to lead Global Drug Development at Novartis
-
Jawed Zia joins as CEO of Cadila Pharma’s Domestic Prescription Business
-
Robin Joffe steps in as PartnerMD of Frost & Sullivan MEASA
-
India develops tiny robots to enhance dental care
-
Fertilis develops new micro device to boost IVF success
-
Japanese population projected to live longer without dementia
-
Singapore makes transparent medical masks for speech therapists
-
Thailand invents rapid detection test for gastrointestinal cancer
-
Korea designs tool for studying inflammatory diseases related to COVID-19
-
Monash University unveils worldclass robotics research facility
-
India to launch Jyoti and Bhupat Mehta School of Health Sciences & Technology
-
Taiwan’s NTHU opens Postbaccalaureate Programme in Medicine
-
Avantor, Inc. invests in manufacturing and distribution hub in Singapore
-
Thermo Fisher, Qatar Genome Program collaborate to advance precision medicine
-
PerkinElmer expands genomic testing services with urWGS
-
BD introduces fully automated infectious disease molecular diagnostic platform
-
Waters, University of Delaware announce opening of Immerse Delaware Lab
-
Sartorius continues global capacity expansion with new extended plant in Tunisia
-
If Seeing Is Believing…